Gvoke VialDx

🇺🇸 United States

FDA Page

Effective Date: Jul 7, 2026
Approval ID: 359982a8-ec5c-4927-8c0f-89771e0f942b
Products: 0 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use GVOKE and GVOKE VialDx safely and effectively. See full prescribing information for GVOKE and GVOKE VialDx. GVOKE (glucagon) injection, for subcutaneous useGVOKE VialDx (glucagon) injection, for intravenous useInitial U.S. Approval: 1960

Quick Stats

Total Products0

Labelers0

Label Sections0

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.